Skip navigation

Study finds link between women's height and cancer risk

(Reuters) - Women's chances of developing cancer after menopause increase with their height, according to a new study. Full story

Women's Cancer Risk Increases with Height

Postmenopausal women who are taller may be at greater risk for developing cancer, new research reveals. Full story

Largest cancer gene database made public

(Reuters) - National Cancer Institute scientists have released the largest-ever database of cancer-related genetic variations, providing researchers the most comprehensive way so far to figure out how to target treatments for the disease. Full story

Melanoma Deaths More Likely in Young Men Than Women

Young men are more likely to die of the skin cancer melanoma than young women, regardless of the severity of the tumor, a new study found. This suggests there are fundamental biological differences between melanoma in men and women, the researchers said. Full story

Rise In Melanoma Treatments

   CNBC's Jackie DeAngelis reports on drug companies making headlines out of the ASCO conference. David Risinger, Morgan Stanley, discusses the rise in melanoma treatments shown at this year's event.

Merck melanoma drug shrinks tumors in 38 percent of patients

CHICAGO (Reuters) - A Merck & Co drug designed to unmask tumor cells and mobilize the immune system into fighting cancer helped shrink tumors in 38 percent of patients with advanced melanoma in an early-stage study, U.S. researchers said on Sunday. Full story

Sponsored Links


Drug is a first to help patients with melanoma of the eye

GSK melanoma drugs add to tally of U.S. drug approvals

FDA approves two Glaxo melanoma drugs

Melanoma treatment uses immune system to kill cancer cells

Bristol-Myers shares jump ahead of melanoma trial data

Amgen's melanoma drug shows promise in key trial

Aspirin tied to lower melanoma risk

Tanning parlors may misinform clients about risks

Is 'Tanning Mom' Another Setback for Sunbed Industry?

New device uses light to screen for melanoma


  Immunotherapy targets cancer cells with remarkable results

Cancer cells typically put up a chemical shield to protect against the body’s disease-fighting T cells. But immunotherapy can break down the shield and let the T cells get to work. NBC’s Robert Bazell reports.